Cargando…

Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond

Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell de...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Junxia, Liu, Dairu, Zhang, Mao, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887687/
https://www.ncbi.nlm.nih.gov/pubmed/29774530
http://dx.doi.org/10.1111/bph.14363
_version_ 1783475070914527232
author Zhang, Junxia
Liu, Dairu
Zhang, Mao
Zhang, Yan
author_facet Zhang, Junxia
Liu, Dairu
Zhang, Mao
Zhang, Yan
author_sort Zhang, Junxia
collection PubMed
description Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell death, whereas necrosis has been regarded to be an unregulated process. Recent findings reveal that necrosis also occurs in a regulated manner and that it is closely related to the physiology and pathophysiology of many organs, including the heart. The recognition of necrosis as a regulated process mandates a re‐examination of cell death in the heart together with the mechanisms and therapy of cardiac diseases. In this study, we summarize the regulatory mechanisms of the programmed necrosis of cardiomyocytes, that is, the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Furthermore, the role of this programmed necrosis in various heart diseases is also delineated. Finally, we describe the currently known pharmacological inhibitors of several of the key regulatory molecules of regulated cell necrosis and the opportunities for their therapeutic use in cardiac disease. We intend to systemically summarize the recent progresses in the regulation and pathological significance of programmed cardiomyocyte necrosis along with its potential therapeutic applications to cardiac diseases. LINKED ARTICLES: This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc
format Online
Article
Text
id pubmed-6887687
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68876872019-12-12 Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond Zhang, Junxia Liu, Dairu Zhang, Mao Zhang, Yan Br J Pharmacol Themed Section: Review Articles Excessive death of cardiac myocytes leads to many cardiac diseases, including myocardial infarction, arrhythmia, heart failure and sudden cardiac death. For the last several decades, most work on cell death has focused on apoptosis, which is generally considered as the only form of regulated cell death, whereas necrosis has been regarded to be an unregulated process. Recent findings reveal that necrosis also occurs in a regulated manner and that it is closely related to the physiology and pathophysiology of many organs, including the heart. The recognition of necrosis as a regulated process mandates a re‐examination of cell death in the heart together with the mechanisms and therapy of cardiac diseases. In this study, we summarize the regulatory mechanisms of the programmed necrosis of cardiomyocytes, that is, the intrinsic (mitochondrial) and extrinsic (death receptor) pathways. Furthermore, the role of this programmed necrosis in various heart diseases is also delineated. Finally, we describe the currently known pharmacological inhibitors of several of the key regulatory molecules of regulated cell necrosis and the opportunities for their therapeutic use in cardiac disease. We intend to systemically summarize the recent progresses in the regulation and pathological significance of programmed cardiomyocyte necrosis along with its potential therapeutic applications to cardiac diseases. LINKED ARTICLES: This article is part of a themed section on Mitochondrial Pharmacology: Featured Mechanisms and Approaches for Therapy Translation. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.22/issuetoc John Wiley and Sons Inc. 2018-06-25 2019-11 /pmc/articles/PMC6887687/ /pubmed/29774530 http://dx.doi.org/10.1111/bph.14363 Text en © 2018 The Authors. British Journal of Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Themed Section: Review Articles
Zhang, Junxia
Liu, Dairu
Zhang, Mao
Zhang, Yan
Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title_full Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title_fullStr Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title_full_unstemmed Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title_short Programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
title_sort programmed necrosis in cardiomyocytes: mitochondria, death receptors and beyond
topic Themed Section: Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6887687/
https://www.ncbi.nlm.nih.gov/pubmed/29774530
http://dx.doi.org/10.1111/bph.14363
work_keys_str_mv AT zhangjunxia programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond
AT liudairu programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond
AT zhangmao programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond
AT zhangyan programmednecrosisincardiomyocytesmitochondriadeathreceptorsandbeyond